AnovaOS Network Powered Patient Registry
Public ClinicalTrials.gov record NCT05013944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT05013944
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Anova Enterprises, Inc
- Industry
- Enrollment
- 100,000 participants
Conditions and interventions
Conditions
- Certain Conditions Originating in the Perinatal Period
- Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)
- Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)
- Diseases of the Circulatory System
- Diseases of the Digestive System
- Diseases of the Ear and Mastoid Process
- Diseases of the Eye and Adnexa
- Diseases of the Genitourinary System
- Diseases of the Musculoskeletal System and Connective Tissue
- Diseases of the Nervous System
- Diseases of the Respiratory System
- Diseases of the Skin and Subcutaneous Tissue
- Endocrine, Nutritional and Metabolic Diseases (E00-E89)
- External Causes of Morbidity and Mortality
- Factors Influencing Health Status and Contact With Health Services
- Infectious Disease
- Injury, Poisoning and Certain Other Consequences of External Causes
- Mental and Behavioural Disorders
- Neoplasms
- Pregnancy, Childbirth and the Puerperium
- Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2021
- Primary completion
- Aug 30, 2025
- Completion
- Aug 30, 2026
- Last update posted
- Jan 29, 2024
2021 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anova Enterprises, Inc. | Arlington Heights | Illinois | 60005 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05013944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05013944 live on ClinicalTrials.gov.